Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Inventory Average (2023 - 2025)

Historic Inventory Average for Krystal Biotech (KRYS) over the last 3 years, with Q4 2025 value amounting to $39.1 million.

  • Krystal Biotech's Inventory Average rose 7322.85% to $39.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $39.1 million, marking a year-over-year increase of 7322.85%. This contributed to the annual value of $33.5 million for FY2025, which is 9999.1% up from last year.
  • Latest data reveals that Krystal Biotech reported Inventory Average of $39.1 million as of Q4 2025, which was up 7322.85% from $34.3 million recorded in Q3 2025.
  • In the past 5 years, Krystal Biotech's Inventory Average ranged from a high of $39.1 million in Q4 2025 and a low of $6.1 million during Q4 2023
  • For the 3-year period, Krystal Biotech's Inventory Average averaged around $21.9 million, with its median value being $22.5 million (2024).
  • Per our database at Business Quant, Krystal Biotech's Inventory Average skyrocketed by 26768.33% in 2024 and then soared by 7322.85% in 2025.
  • Krystal Biotech's Inventory Average (Quarter) stood at $6.1 million in 2023, then surged by 267.68% to $22.5 million in 2024, then surged by 73.23% to $39.1 million in 2025.
  • Its last three reported values are $39.1 million in Q4 2025, $34.3 million for Q3 2025, and $30.5 million during Q2 2025.